Tag: Patient Safety

Supply chain stability improves, but threats remain

Editor's Note Released April 9 by the Association for Supply Chain Management (ASCM) and KPMG LLP,  the KPMG Supply Chain Stability Index reveals an overall improvement in supply chain stability throughout 2023. However, points of weakness persist. According to the index, factors preventing a complete return to pre-pandemic normalcy include the…

Read More

By: Matt Danford
April 23, 2024
Share

FDA approves imaging drug for detecting cancer after lumpectomy

Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

By: Matt Danford
April 22, 2024
Share

Surface disinfection: How to play your cards right with UVC light

Approximately one in 31 hospital patients has at least one infection on any given day, according to the Centers for Disease Control and Prevention (CDC). In surgical settings, the risk is even higher, with up to 7% of patients developing an infection during surgery. These infections can lead to a…

Read More

By: Tra Vu, PhD
April 19, 2024
Share

Unveiling ECRI’s 2024 Top 10 Patient Safety Concerns list

From integrating new technology to navigating shifts in care delivery and mitigating burnout, the most pressing challenges for healthcare organizations tend to be multifaceted problems that demand multifaceted solutions. For evidence of that, look no further than the Top 10 Patient Safety Concerns 2024 list from ECRI. For every risk…

Read More

By: Heather David, MSN, CRNP, AGACNP-BC, CSSYB
April 19, 2024
Share

Survey assesses continued impact of Change Healthcare cyberattack

Editor's Note Fallout from the February 21 cyberattack on Change Healthcare continues to threaten physician practices and their patients nationwide, with respondents to a recent American Medical Association (AMA) survey indicating difficulties with insurance claims and eligibility verification. AMA published the results of the informal survey April 10. Conducted March…

Read More

By: Matt Danford
April 19, 2024
Share

Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes

Editor's Note Medical management care with evacuation surgery could yield better 180-day outcomes than without in patents treated within 24 hours for acute intracerebral hemorrhage, according to study results covered in an April 10 MedPage Today report. The ENRICH (Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)) trial is a multicenter,…

Read More

By: Matt Danford
April 18, 2024
Share

Drug shortages higher than ever

Editor's Note Shortages of active drugs in the US have reached a new record, according to an April 12 CNN report on data from the American Society of Health-System Pharmacists and the University of Utah Drug Information Service. The two organizations have been tracking this data since 2001, the CNN report says.…

Read More

By: Matt Danford
April 18, 2024
Share

FDA announces class 1 recalls for premixed embolic, infusion pump software

Editor's Note The US Food and Drug Administration has classified recalls of Boston Scientific’s Obsidio Conformable Embolic and Fresenius Kabi USA’s Ivenix Infusion System Large Volume Pump (LVP) software as class 1, the most serious category and an indicator of risk of serious injury or death. No injuries or deaths…

Read More

By: Matt Danford
April 18, 2024
Share

Propofol anesthesia for colonoscopy could help find polyps, prevent cancer

Editor's Note By putting the patient into deeper sedation during colonoscopy, propofol could help doctors find difficult-to-spot, potentially cancerous “serrated” polyps, according to a study published April 17 in Anesthesiology. As an alternative to moderate, “conscious” sedation, propofol facilitates a more thorough exam that is more likely to identify serrated…

Read More

By: Matt Danford
April 17, 2024
Share

FDA Class 1 recall renews concern about historically problematic heart pumps

The US Food & Drug Administration (FDA) announced a Class 1 recall on Monday for Abbott/Thoratec Corp.’s HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due due to biological material buildup obstructing the devices. According to an April 16 CBS News report, surgeons first noticed problems with the…

Read More

By: Matt Danford
April 17, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat